Home >> Signaling Pathways >> Angiogenesis >> Integrin

Integrin(整合素)

Intergrin is a cell adhesion receptor for extracellular matrix protein binding. It is also involved in cell to cell interaction and triggers a variety of signaling pathways for cell proliferation, survival and mobility etc.

  1. Cat.No. 产品名称 Information
  2. GC67708 PLN-1474
  3. GC65909 Bexotegrast
  4. GC65597 Abciximab
  5. GC65455 c(phg-isoDGR-(NMe)k)
  6. GC64932 αvβ5 integrin-IN-1
  7. GC64571 Sibrafiban
  8. GC64212 Valategrast hydrochloride
  9. GC63490 Valategrast
  10. GC62872 BMS-587101
  11. GC62566 αvβ1 integrin-IN-1 TFA
  12. GC62397 RO0270608
  13. GC62380 αvβ1 integrin-IN-1
  14. GC62182 Echistatin TFA
  15. GC62143 Carotegrast methyl
  16. GC61613 Integrin modulator 1
  17. GC61520 Cilengitide TFA An integrin αVβ3 receptor antagonist
  18. GC61323 Tetrac
  19. GC61109 Natalizumab
  20. GC60200 ILK-IN-3 ILK-IN-3 is an integrin linked kinase (ILK) inhibitor with antitumor activity.
  21. GC60117 Cyclo(-RGDfK) TFA An inhibitor of αvβ3 integrin
  22. GC60077 BIO5192 hydrate
  23. GC50642 LDV LDV 是一种三肽,是 LDV-FITC 的非荧光类似物。
  24. GC50325 BOP BOP 是一种有效和选择性的双重 α9β1/α4β1 整合素抑制剂,Kd 值在皮摩尔范围内。
  25. GC50078 BIRT 377 BIRT 377 是一种有效的口服生物利用度抑制剂,可抑制细胞间粘附分子-1 (ICAM-1) 和淋巴细胞功能相关抗原-1 (LFA-1) 之间的相互作用,Ki 为 25.8 nM。
  26. GC50075 BTT 3033 BTT 3033 是一种口服活性的 α2β1 (EC50: 130 nM) 构象选择性抑制剂,通过与 α2I 结构域结合。
  27. GC38893 BMS-688521
  28. GC38873 α2β1 Integrin Ligand Peptide TFA
  29. GC38801 Irigenin An isoflavonoid with diverse biological activities
  30. GC38128 c(phg-isoD-G-R-(NMe)k) TFA
  31. GA21306 Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) c(RGDyK) has been radioiodinated or modified with chelators for use as radiopharmaceutical.
  32. GC37975 α2β1 Integrin Ligand Peptide
  33. GC37962 Zaurategrast ethyl ester sulfate
  34. GC37961 Zaurategrast ethyl ester
  35. GC37960 Zaurategrast
  36. GC37818 TR-14035 TR-14035 (SB 683698, MDK-1191) is a a dual alpha4beta (α4β) integrin antagonist with IC50 of 7 nM and 87 nM for alpha4beta7 (α4β7) and alpha4beta1 (α4β1), respectively.
  37. GC37541 Risuteganib An anti-integrin peptide
  38. GC37524 RGD peptide (GRGDNP) TFA An inhibitor of integrin-ligand interactions
  39. GC36821 OSU-T315 OSU-T315 (ILK-IN-2) is a potent Integrin-Linked Kinase (ILK) inhibitor with IC50 of 0.6 μM. OSU-T315 induces autophagy and apoptosis, both of which are integral to its antiproliferative activity. OSU-T315 exhibits anti-tumor activity.
  40. GC36500 LXW7
  41. GC34402 RGD Trifluoroacetate
  42. GC34301 ILK-IN-2 An ILK inhibitor
  43. GC34265 GRGDSP TFA
  44. GC34211 Vedolizumab Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
  45. GC34141 Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA
  46. GC34133 ATN-161 An integrin receptor antagonist
  47. GC33837 ATN-161 trifluoroacetate salt (ATN-161 TFA salt) An integrin receptor antagonist
  48. GC33323 GRGDSP
  49. GC32967 Integrin Antagonists 27
  50. GC32787 iRGD peptide (c(CRGDKGPDC))
  51. GC32562 Fradafiban (BIBU-52)

Items 1 to 50 of 84 total

per page
  1. 1
  2. 2

Set Descending Direction